Nantong Guangyuan Chemical (revision 15)
Old revision·20:29, 23 Sep 2024·ChainCustodyChad
| Nantong Guangyuan Chemical Co., Ltd. | |
|---|---|
| Legal name | Nantong Guangyuan Chemical Co., Ltd. |
| Trading name | GGPeps |
| Other designations | GYC, GYC Peptides, Guangyuan Chemical |
| Organisation infobox · conventions | |
Nantong Guangyuan Chemical Co., Ltd. (trading as GGPeps; ggpeps.net) is a peptide supplier based in Nantong, Jiangsu, China, trading under several designations including GGPeps and GYC, operating a distributed warehouse network and with a substantial associated third-party testing record.[1][2]
The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]The organisation operates from Nantong, Jiangsu, within the Yangtze delta manufacturing belt.[1] No incorporation year is documented in sources available to this wiki and none is asserted here.
It trades under several designations — a registered chemical-company name and at least two shorter trading names — and purchaser reports use them interchangeably.[5] The multiplicity is the most practically consequential fact about the organisation for a reader attempting verification, since material discussed under one designation may not obviously be the same organisation as material discussed under another. The article lists all of them in its opening sentence for that reason.
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe a distributed warehouse arrangement, with orders fulfilled from regional stock as well as from China, and correspondingly variable transit times and customs exposure.[5] Certificate content in the submitted set has been middling: purity and appearance consistently, water and method inconsistently.[6]
References
- ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ a b Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.